Cost-Effectiveness Assessment of Telaprevir Combination Treatment Compared to Pegylated-Interferon+Ribavirin Alone in the Management of Hepatitis C in Patients who Failed Prior Pegylated-Interferon+Ribavirin Treatment: 2011 ACG Presidential Poster: 1099